1. Home
  2. DYN vs BKU Comparison

DYN vs BKU Comparison

Compare DYN & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • BKU
  • Stock Information
  • Founded
  • DYN 1984
  • BKU 2009
  • Country
  • DYN United States
  • BKU United States
  • Employees
  • DYN N/A
  • BKU N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • BKU Savings Institutions
  • Sector
  • DYN Health Care
  • BKU Finance
  • Exchange
  • DYN Nasdaq
  • BKU Nasdaq
  • Market Cap
  • DYN 2.6B
  • BKU 2.8B
  • IPO Year
  • DYN 2020
  • BKU 2011
  • Fundamental
  • Price
  • DYN $14.13
  • BKU $39.79
  • Analyst Decision
  • DYN Strong Buy
  • BKU Hold
  • Analyst Count
  • DYN 10
  • BKU 10
  • Target Price
  • DYN $50.70
  • BKU $41.30
  • AVG Volume (30 Days)
  • DYN 1.8M
  • BKU 740.4K
  • Earning Date
  • DYN 03-04-2025
  • BKU 01-22-2025
  • Dividend Yield
  • DYN N/A
  • BKU 2.91%
  • EPS Growth
  • DYN N/A
  • BKU N/A
  • EPS
  • DYN N/A
  • BKU 2.44
  • Revenue
  • DYN N/A
  • BKU $919,935,000.00
  • Revenue This Year
  • DYN N/A
  • BKU N/A
  • Revenue Next Year
  • DYN N/A
  • BKU $7.23
  • P/E Ratio
  • DYN N/A
  • BKU $16.30
  • Revenue Growth
  • DYN N/A
  • BKU 3.57
  • 52 Week Low
  • DYN $14.03
  • BKU $24.34
  • 52 Week High
  • DYN $47.45
  • BKU $44.45
  • Technical
  • Relative Strength Index (RSI)
  • DYN 19.54
  • BKU 55.07
  • Support Level
  • DYN $14.79
  • BKU $39.04
  • Resistance Level
  • DYN $15.90
  • BKU $40.85
  • Average True Range (ATR)
  • DYN 1.55
  • BKU 1.03
  • MACD
  • DYN -0.82
  • BKU 0.21
  • Stochastic Oscillator
  • DYN 0.82
  • BKU 76.70

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

Share on Social Networks: